BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16716165)

  • 1. Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A.
    Abdel-Naser MB; El-Khateeb EA; Sallam TH; Habib MA
    Clin Exp Dermatol; 2006 Jul; 31(4):571-5. PubMed ID: 16716165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
    Caca-Biljanovska NG; V'lckova-Laskoska MT
    Croat Med J; 2002 Dec; 43(6):707-12. PubMed ID: 12476481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study).
    El-Mofty M; El Weshahy H; Youssef R; Abdel-Halim M; Mashaly H; El Hawary M
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):38-42. PubMed ID: 18201356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study.
    Valbuena MC; Hernández O; Rey M; Sánchez G; de Quintana LP
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):126-9. PubMed ID: 17598865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
    Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
    Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA.
    Akyol M; Celik VK; Ozcelik S; Polat M; Marufihah M; Atalay A
    Eur J Dermatol; 2002; 12(1):24-6. PubMed ID: 11809591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy.
    Souteiro P; Vieira-Coelho MA; Serrão MP; Magina S
    Photodermatol Photoimmunol Photomed; 2013 Oct; 29(5):227-32. PubMed ID: 24001377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUVA therapy.
    Helm TN; Dijkstra JW; Ferrara RJ; Glanz S
    Am Fam Physician; 1991 Mar; 43(3):908-12. PubMed ID: 2000735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Psoralen ultraviolet A (PUVA) photochemotherapy plus topical corticosteroids with PUVA plus bland emollients in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Ayub Med Coll Abbottabad; 2005; 17(1):34-6. PubMed ID: 15929524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.